DK1007023T3 - 1-[1-(4-chlorphenyl)cyclobutyl]-3-methylbutylaminderivater til sænkning af urinniveauet hos mennesker - Google Patents
1-[1-(4-chlorphenyl)cyclobutyl]-3-methylbutylaminderivater til sænkning af urinniveauet hos menneskerInfo
- Publication number
- DK1007023T3 DK1007023T3 DK97942030T DK97942030T DK1007023T3 DK 1007023 T3 DK1007023 T3 DK 1007023T3 DK 97942030 T DK97942030 T DK 97942030T DK 97942030 T DK97942030 T DK 97942030T DK 1007023 T3 DK1007023 T3 DK 1007023T3
- Authority
- DK
- Denmark
- Prior art keywords
- humans
- pct
- cyclobutyl
- chlorophenyl
- methylbutylamine
- Prior art date
Links
- WQSACWZKKZPCHN-UHFFFAOYSA-N 1-[1-(4-chlorophenyl)cyclobutyl]-3-methylbutan-1-amine Chemical class C=1C=C(Cl)C=CC=1C1(C(N)CC(C)C)CCC1 WQSACWZKKZPCHN-UHFFFAOYSA-N 0.000 title 1
- 210000002700 urine Anatomy 0.000 title 1
- 201000005569 Gout Diseases 0.000 abstract 1
- 201000001431 Hyperuricemia Diseases 0.000 abstract 1
- LEHOTFFKMJEONL-UHFFFAOYSA-N Uric Acid Chemical compound N1C(=O)NC(=O)C2=C1NC(=O)N2 LEHOTFFKMJEONL-UHFFFAOYSA-N 0.000 abstract 1
- TVWHNULVHGKJHS-UHFFFAOYSA-N Uric acid Natural products N1C(=O)NC(=O)C2NC(=O)NC21 TVWHNULVHGKJHS-UHFFFAOYSA-N 0.000 abstract 1
- UWAOJIWUVCMBAZ-UHFFFAOYSA-N [1-[1-(4-chlorophenyl)cyclobutyl]-3-methylbutyl]-dimethylazanium;chloride Chemical compound Cl.C=1C=C(Cl)C=CC=1C1(C(N(C)C)CC(C)C)CCC1 UWAOJIWUVCMBAZ-UHFFFAOYSA-N 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 208000029078 coronary artery disease Diseases 0.000 abstract 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 abstract 1
- 150000004682 monohydrates Chemical class 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 229940116269 uric acid Drugs 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Urology & Nephrology (AREA)
- Physical Education & Sports Medicine (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Materials For Medical Uses (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Crystals, And After-Treatments Of Crystals (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9619962.5A GB9619962D0 (en) | 1996-09-25 | 1996-09-25 | Medical treatment |
| PCT/EP1997/005034 WO1998013033A1 (en) | 1996-09-25 | 1997-09-15 | Medical treatment |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1007023T3 true DK1007023T3 (da) | 2003-08-25 |
Family
ID=10800448
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK97942030T DK1007023T3 (da) | 1996-09-25 | 1997-09-15 | 1-[1-(4-chlorphenyl)cyclobutyl]-3-methylbutylaminderivater til sænkning af urinniveauet hos mennesker |
Country Status (26)
| Country | Link |
|---|---|
| US (1) | US6162831A (da) |
| EP (1) | EP1007023B1 (da) |
| JP (1) | JP2001501608A (da) |
| KR (1) | KR20000048568A (da) |
| CN (1) | CN1231604A (da) |
| AT (1) | ATE239460T1 (da) |
| AU (1) | AU722129B2 (da) |
| BG (1) | BG103278A (da) |
| BR (1) | BR9711414A (da) |
| CA (1) | CA2266438A1 (da) |
| DE (1) | DE69721838T2 (da) |
| DK (1) | DK1007023T3 (da) |
| ES (1) | ES2199374T3 (da) |
| GB (1) | GB9619962D0 (da) |
| HR (1) | HRP970519A2 (da) |
| HU (1) | HUP9904545A3 (da) |
| IL (1) | IL128851A (da) |
| NO (1) | NO991425D0 (da) |
| NZ (1) | NZ334668A (da) |
| PL (1) | PL332423A1 (da) |
| PT (1) | PT1007023E (da) |
| SK (1) | SK32199A3 (da) |
| TR (1) | TR199900649T2 (da) |
| TW (1) | TW415842B (da) |
| WO (1) | WO1998013033A1 (da) |
| ZA (1) | ZA978573B (da) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6339106B1 (en) | 1999-08-11 | 2002-01-15 | Sepracor, Inc. | Methods and compositions for the treatment and prevention of sexual dysfunction |
| US6974838B2 (en) | 1998-08-24 | 2005-12-13 | Sepracor Inc. | Methods of treating or preventing pain using sibutramine metabolites |
| US6476078B2 (en) | 1999-08-11 | 2002-11-05 | Sepracor, Inc. | Methods of using sibutramine metabolites in combination with a phosphodiesterase inhibitor to treat sexual dysfunction |
| US6331571B1 (en) | 1998-08-24 | 2001-12-18 | Sepracor, Inc. | Methods of treating and preventing attention deficit disorders |
| US6552087B1 (en) | 1999-03-19 | 2003-04-22 | Abbott Gmbh & Co. Kg | Therapeutic agent comprising (+)-sibutramine |
| IL145238A0 (en) * | 1999-03-19 | 2002-06-30 | Knoll Gmbh | Treatment of osteoarthritis |
| US6399826B1 (en) | 1999-08-11 | 2002-06-04 | Sepracor Inc. | Salts of sibutramine metabolites, methods of making sibutramine metabolites and intermediates useful in the same, and methods of treating pain |
| US6610887B2 (en) | 2001-04-13 | 2003-08-26 | Sepracor Inc. | Methods of preparing didesmethylsibutramine and other sibutramine derivatives |
| US9655932B2 (en) * | 2002-03-13 | 2017-05-23 | Kibow Biotech, Inc. | Composition and method for preventing or treating gout or hyperuricemia |
| US11103542B2 (en) | 2002-03-13 | 2021-08-31 | Kibow Biotech, Inc. | Composition and method for maintaining healthy kidney function |
| JP4278652B2 (ja) * | 2002-10-05 | 2009-06-17 | ハンミ ファーム． シーオー．， エルティーディー． | 結晶性シブトラミンメタンスルホン酸塩半水和物を含む医薬組成物 |
| US20050131074A1 (en) * | 2003-08-04 | 2005-06-16 | Beckman Kristen M. | Methods for treating metabolic syndrome |
| US8557831B2 (en) * | 2004-07-21 | 2013-10-15 | University Of Florida Research Foundation, Inc. | Compositions and methods for treatment and prevention of insulin resistance |
| KR100627687B1 (ko) * | 2005-04-20 | 2006-09-25 | 주식회사 씨티씨바이오 | 시부트라민 유리염기 함유 조성물 및 이의 제조방법 |
| KR20080046601A (ko) * | 2006-11-22 | 2008-05-27 | 에스케이케미칼주식회사 | 보관안정성이 우수한 시부트라민 함유 포접복합체 |
| US11179426B2 (en) | 2016-12-29 | 2021-11-23 | Kibow Biotech, Inc. | Composition and method for maintaining healthy kidney function |
| JP2022536222A (ja) * | 2018-11-02 | 2022-08-15 | アンパサンド バイオファーマシューティカルズ インコーポレイテッド | 局所的に施用される緩衝液によるカチオン過負荷および電解質平衡異常のリスクの管理 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IE52768B1 (en) * | 1981-04-06 | 1988-02-17 | Boots Co Ltd | 1-arylcyclobutylalkylamine compounds useful as therapeutic agents |
| GB8531071D0 (en) * | 1985-12-17 | 1986-01-29 | Boots Co Plc | Therapeutic compound |
| GB8704777D0 (en) * | 1987-02-28 | 1987-04-01 | Boots Co Plc | Medical treatment |
| JP2675573B2 (ja) * | 1988-03-31 | 1997-11-12 | 科研製薬株式会社 | 脳機能改善剤 |
| IE61928B1 (en) * | 1988-11-29 | 1994-11-30 | Boots Co Plc | Treatment of obesity |
| AU4542893A (en) * | 1992-06-23 | 1994-01-24 | Sepracor, Inc. | Methods and compositions for treating depression and other disorders using optically pure (-) sibutramine |
| AU4542993A (en) * | 1992-06-23 | 1994-01-24 | Sepracor, Inc. | Methods and compositions for treating depression and other disorders using optically pure (+) sibutramine |
| US5459164A (en) * | 1994-02-03 | 1995-10-17 | Boots Pharmaceuticals, Inc. | Medical treatment |
-
1996
- 1996-09-25 GB GBGB9619962.5A patent/GB9619962D0/en active Pending
-
1997
- 1997-09-15 PT PT97942030T patent/PT1007023E/pt unknown
- 1997-09-15 DK DK97942030T patent/DK1007023T3/da active
- 1997-09-15 TR TR1999/00649T patent/TR199900649T2/xx unknown
- 1997-09-15 WO PCT/EP1997/005034 patent/WO1998013033A1/en not_active Ceased
- 1997-09-15 SK SK321-99A patent/SK32199A3/sk unknown
- 1997-09-15 HU HU9904545A patent/HUP9904545A3/hu unknown
- 1997-09-15 EP EP97942030A patent/EP1007023B1/en not_active Expired - Lifetime
- 1997-09-15 IL IL12885197A patent/IL128851A/xx not_active IP Right Cessation
- 1997-09-15 US US09/269,339 patent/US6162831A/en not_active Expired - Fee Related
- 1997-09-15 DE DE69721838T patent/DE69721838T2/de not_active Expired - Fee Related
- 1997-09-15 AU AU43851/97A patent/AU722129B2/en not_active Ceased
- 1997-09-15 KR KR1019990702491A patent/KR20000048568A/ko not_active Ceased
- 1997-09-15 NZ NZ334668A patent/NZ334668A/xx unknown
- 1997-09-15 ES ES97942030T patent/ES2199374T3/es not_active Expired - Lifetime
- 1997-09-15 PL PL97332423A patent/PL332423A1/xx unknown
- 1997-09-15 AT AT97942030T patent/ATE239460T1/de not_active IP Right Cessation
- 1997-09-15 CN CN97198232A patent/CN1231604A/zh active Pending
- 1997-09-15 JP JP10515217A patent/JP2001501608A/ja active Pending
- 1997-09-15 CA CA002266438A patent/CA2266438A1/en not_active Abandoned
- 1997-09-15 BR BR9711414-6A patent/BR9711414A/pt not_active Application Discontinuation
- 1997-09-25 ZA ZA978573A patent/ZA978573B/xx unknown
- 1997-09-25 HR HR9619962.5A patent/HRP970519A2/hr not_active Application Discontinuation
- 1997-09-25 TW TW086113992A patent/TW415842B/zh not_active IP Right Cessation
-
1999
- 1999-03-24 BG BG103278A patent/BG103278A/xx unknown
- 1999-03-24 NO NO991425A patent/NO991425D0/no unknown
Also Published As
| Publication number | Publication date |
|---|---|
| DE69721838D1 (de) | 2003-06-12 |
| CN1231604A (zh) | 1999-10-13 |
| DE69721838T2 (de) | 2004-01-22 |
| IL128851A (en) | 2001-08-26 |
| PT1007023E (pt) | 2003-08-29 |
| ES2199374T3 (es) | 2004-02-16 |
| BR9711414A (pt) | 2000-04-25 |
| HUP9904545A3 (en) | 2000-12-28 |
| CA2266438A1 (en) | 1998-04-02 |
| AU4385197A (en) | 1998-04-17 |
| ATE239460T1 (de) | 2003-05-15 |
| BG103278A (en) | 2000-01-31 |
| NO991425L (no) | 1999-03-24 |
| PL332423A1 (en) | 1999-09-13 |
| EP1007023A1 (en) | 2000-06-14 |
| JP2001501608A (ja) | 2001-02-06 |
| EP1007023B1 (en) | 2003-05-07 |
| SK32199A3 (en) | 1999-12-10 |
| HUP9904545A2 (hu) | 2000-11-28 |
| NZ334668A (en) | 2000-07-28 |
| KR20000048568A (ko) | 2000-07-25 |
| TR199900649T2 (xx) | 1999-07-21 |
| TW415842B (en) | 2000-12-21 |
| IL128851A0 (en) | 2000-01-31 |
| US6162831A (en) | 2000-12-19 |
| WO1998013033A1 (en) | 1998-04-02 |
| HRP970519A2 (en) | 1998-08-31 |
| NO991425D0 (no) | 1999-03-24 |
| AU722129B2 (en) | 2000-07-20 |
| ZA978573B (en) | 1999-03-25 |
| GB9619962D0 (en) | 1996-11-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK1007023T3 (da) | 1-[1-(4-chlorphenyl)cyclobutyl]-3-methylbutylaminderivater til sænkning af urinniveauet hos mennesker | |
| NO20014479D0 (no) | Fremgangsmåte ved behandling av spiseforstyrrelser | |
| NO20021328L (no) | Pyrazolopyrimidier som terapeutiske midler | |
| KR950016725A (ko) | 폐 고혈압성 질병을 억제하는 방법 | |
| WO2000056315A8 (en) | Treatment of pain | |
| DK1169029T3 (da) | Anvendelse af sibutramin eller et derivat deraf til behandling af sövnforstyrrelser | |
| MXPA01009468A (es) | Tratamiento de hipertension pulmonar. | |
| BG106000A (en) | Treatment of hiatial hernia | |
| MXPA01009461A (es) | Tratamiento de osteoartritis. | |
| KR950016739A (ko) | 강박관념 질환 및 소모성 질환을 억제하는 방법 | |
| MXPA01009465A (es) | Perdida de peso despues del embarazo. | |
| BG105996A (en) | Method of treating eating disorders |